Parsec Financial Management, Inc. Theratechnologies Inc. Transaction History

Parsec Financial Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$2.2 - $3.94 $4,400 - $7,880	-2,000 Reduced 11.05%	16,100 $62,000
Q3 2020 Nov 06, 2020	BUY	$1.96 - $2.92 $6,468 - $9,636	3,300 Added 22.3%	18,100 $40,000
Q1 2020 May 08, 2020	SELL	$1.43 - $3.23 $16,945 - $38,275	-11,850 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$2.74 - $4.2 $32,469 - $49,770	11,850 New	11,850 $39,000
Q2 2018 Jul 26, 2018	SELL	$7.09 - $11.24 $92,170 - $146,120	-13,000 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$5.64 - $6.24 $73,320 - $81,120	13,000	13,000 $79,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $114M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Parsec Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Parsec Financial Management, Inc. with notifications on news.